339 related articles for article (PubMed ID: 11737656)
21. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.
Onoue S; Imai T; Kumada H; Umemoto T; Kaca W; Isshiki Y; Kaneko A; Kawahara K
Microbiol Immunol; 2003; 47(1):51-5. PubMed ID: 12636253
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341
[TBL] [Abstract][Full Text] [Related]
23. Characterization of T lymphocyte clones derived from Porphyromonas gingivalis infected subjects.
Gemmell E; Woodford V; Seymour GJ
J Periodontal Res; 1996 Jan; 31(1):47-56. PubMed ID: 8636876
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity to Porphyromonas gingivalis infection in a murine model.
Bird PS; Gemmell E; Polak B; Paton RG; Sosroseno W; Seymour GJ
J Periodontol; 1995 May; 66(5):351-62. PubMed ID: 7623254
[TBL] [Abstract][Full Text] [Related]
25. Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum.
Ebersole JL; Feuille F; Kesavalu L; Holt SC
Microb Pathog; 1997 Jul; 23(1):23-32. PubMed ID: 9250777
[TBL] [Abstract][Full Text] [Related]
26. Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model.
Gemmell E; Winning TA; Bird PS; Seymour GJ
J Periodontol; 1998 Oct; 69(10):1131-8. PubMed ID: 9802713
[TBL] [Abstract][Full Text] [Related]
27. The role of cytokines in a Porphyromonas gingivalis-induced murine abscess model.
Alayan J; Gemmell E; Ford P; Hamlet S; Bird PS; Ivanovski S; Farah CS
Oral Microbiol Immunol; 2007 Oct; 22(5):304-12. PubMed ID: 17803627
[TBL] [Abstract][Full Text] [Related]
28. Porphyromonas gingivalis B cell Antigen Epitope Vaccine, pIRES-ragB'-mGITRL, Promoted RagB-Specific Antibody Production and Tfh Cells Expansion.
Kong F; Zheng D; She P; Ni P; Zhu H; Xu H; Su Z
Scand J Immunol; 2015 Jun; 81(6):476-82. PubMed ID: 25689343
[TBL] [Abstract][Full Text] [Related]
29. Humoral and cellular immune responses to the fimbriae of Porphyromonas gingivalis and their synthetic peptides.
Ogawa T; Ogo H; Uchida H; Hamada S
J Med Microbiol; 1994 Jun; 40(6):397-402. PubMed ID: 7911839
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum impairs serum binding to Porphyromonas gingivalis biofilm.
Choi JI; Kim US; Kim SJ; Son WS; Park HR
Oral Microbiol Immunol; 2003 Apr; 18(2):92-4. PubMed ID: 12654097
[TBL] [Abstract][Full Text] [Related]
31. The effect of monoclonal antibody and route of immunization on the humoral immune response against Porphyromonas gingivalis.
Van Tilburg ML; Kozarov EV; Progulske-Fox A; Brady LJ
Oral Microbiol Immunol; 2001 Jun; 16(3):153-62. PubMed ID: 11358537
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-8 and intercellular adhesion molecule 1 regulation in oral epithelial cells by selected periodontal bacteria: multiple effects of Porphyromonas gingivalis via antagonistic mechanisms.
Huang GT; Kim D; Lee JK; Kuramitsu HK; Haake SK
Infect Immun; 2001 Mar; 69(3):1364-72. PubMed ID: 11179300
[TBL] [Abstract][Full Text] [Related]
33. The potential protective immune responses to synthetic peptides containing conserved epitopes of Porphyromonas gingivalis fimbrial protein.
Ogawa T
J Med Microbiol; 1994 Nov; 41(5):349-58. PubMed ID: 7966208
[TBL] [Abstract][Full Text] [Related]
34. Porphyromonas gingivalis antibody levels and diagnosis of coronary artery disease in HIV-positive individuals.
Berquist VL; Hearps AC; Ford P; Jaworowski A; Leishman SJ; Hoy JF; Trevillyan JM
J Periodontal Res; 2017 Oct; 52(5):930-935. PubMed ID: 28397248
[TBL] [Abstract][Full Text] [Related]
35. Natural killer T cells mediate alveolar bone resorption and a systemic inflammatory response in response to oral infection of mice with Porphyromonas gingivalis.
Aoki-Nonaka Y; Nakajima T; Miyauchi S; Miyazawa H; Yamada H; Domon H; Tabeta K; Yamazaki K
J Periodontal Res; 2014 Feb; 49(1):69-76. PubMed ID: 23586756
[TBL] [Abstract][Full Text] [Related]
36. Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes.
Choi JI; Schifferle RE; Yoshimura F; Kim BW
Infect Immun; 1998 Jan; 66(1):391-3. PubMed ID: 9423888
[TBL] [Abstract][Full Text] [Related]
37. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection.
Polak D; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2012 Jul; 39(7):617-25. PubMed ID: 22607053
[TBL] [Abstract][Full Text] [Related]
38. Antibody responses to Porphyromonas gingivalis infection in a murine abscess model--involvement of gingipains and responses to re-infection.
Yoneda M; Hirofuji T; Motooka N; Anan H; Hamachi T; Miura M; Ishihara Y; Maeda K
J Periodontal Res; 2003 Dec; 38(6):551-6. PubMed ID: 14632916
[TBL] [Abstract][Full Text] [Related]
39. Virulence mechanism of bacteria in mixed infection: attenuation of cytokine levels and evasion of polymorphonuclear leukocyte phagocytosis.
Polak D; Shapira L; Weiss EI; Houri-Haddad Y
J Periodontol; 2013 Oct; 84(10):1463-8. PubMed ID: 23259412
[TBL] [Abstract][Full Text] [Related]
40. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
